Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Case Comprehensive Cancer Center
University of Washington
University of Louisville
City of Hope Medical Center
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center